Please Read Our Disclaimer

Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM

Scientific Review: CCCA Critique – Thomas COVID-19 Vaccines 6 months NEJM

We present several concerns regarding the recent article by Thomas et al. (2) on the efficacy and

safety of the BNT162b2 mRNA coronavirus disease (COVID-19) vaccine, which was published in the

New England Journal of Medicine (NEJM) on November 4, 2021.

Tags: adolescents, adverse effects, adverse events, BNT162b2, CCCA, conflict of interest, COVID, COVID-19, Critique, NEJM, Pfizer, placebo, SAE, SARS-CoV-2, Scientific review, study, Thomas et al, vaccines, virology

Share:

Related Posts

Professor Arne Burkhardt Video

Agile Regulations

Dr. Pelech’s NCI Presentation

Search

Top Categories

WANT TO BECOME A MEMBER?

To learn more about how you can join the Canadian Covid Care Alliance click the link below.

Popular Posts

Florida’s Surgeon General challenges the FDA and CDC.

The balance of risks and benefits in the COVID-19 “vaccine hesitancy” literature: An umbrella review

Left unchecked, the arbitrary power of the College of Physicians and Surgeons of BC threatens the health and well-being of all British Columbians as well as the core values of Canadian democracy

Real Time Ethics – About Misinformation, Disinformation, and Scientific Discourse

The Endemic Hypothesis: Infectious Clones and Virus Isolation

Stay Connected

Canadian Covid Care Alliance